Evidence map›Paper›PMID 35978140›Full record

ArticleEuropean journal of human genetics : EJHG2023

Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder.

Kingsley Wong, Mohammed Junaid, Scott Demarest, Jacinta Saldaris, Tim A Benke, Eric D Marsh, Jenny Downs, Helen Leonard

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Exploring sleep challenges in CDKL5 Deficiency Disorder.Journal of neurodevelopmental disorders · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description.American journal on intellectual and developmental disabilities · 2024
    Article
  9. Article
  10. Article
  11. The value of exomes across the ages.European journal of human genetics : EJHG · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kingsley WongTelethon Kids Institute, The University of Western Australia, Perth, WA, Australia.
Mohammed JunaidTelethon Kids Institute, The University of Western Australia, Perth, WA, Australia.
Scott DemarestChildren's Hospital Colorado, Pediatric Neurology, University of Colorado School of Medicine, Aurora, USA.
Jacinta SaldarisTelethon Kids Institute, The University of Western Australia, Perth, WA, Australia.
Tim A BenkeChildren's Hospital Colorado, Pediatric Neurology, University of Colorado School of Medicine, Aurora, USA.
Eric D MarshDivision of Neurology, Children's Hospital of Philadelphia, School of Medicine, University of Pennsylvania, Philadelphia, USA.
Jenny DownsTelethon Kids Institute, The University of Western Australia, Perth, WA, Australia.
Helen LeonardTelethon Kids Institute, The University of Western Australia, Perth, WA, Australia. helen.leonard@uwa.edu.au.ORCID 0000-0001-6405-5834
The Kids Research Institute Australia · AUChildren's Hospital Colorado · USChildren's Hospital of Philadelphia · US

Funding

Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency DisorderU01NS114312 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BENKE, TIMOTHY A, DOWNS, JENNY · 2021 to 2025
$4.7M
NINDS NIH HHS U01 NS114312
6 · The paper itself

Abstract

This study investigated the influence of factors at birth and in infancy on the likelihood of achieving major motor milestones in CDKL5 Deficiency Disorder (CDD). Data on 350 individuals with a pathogenic CDKL5 variant was sourced from the International CDKL5 Disorder Database. A first model included factors available at birth (e.g., sex, variant group and mosaicism) and the second additionally included factors available during infancy (e.g., age at seizure onset, number of anti-seizure medications used, experience of a honeymoon period and formal therapy). Cox regression was used to model the time to achieve the milestones. The probability of attaining the outcomes at specific ages was estimated by evaluating the time-to-event function at specific covariate values. Independent sitting and walking were achieved by 177/350 and 57/325 children respectively. By seven years of age, 67.1% of females but only 37.3% of males could sit independently. About a quarter each of females and males achieved independent walking by eight and six years, respectively. When observed from birth, female gender, a late truncating variant and mosaicism impacted most positively on the likelihood of independent sitting. When observed from one year, later seizure onset and experiencing a honeymoon period also improved the likelihood of independent sitting. Factors that favoured sitting (except gender) also improved walking. Having a truncating variant between aa178 and aa781 reduced the likelihood of achieving independent sitting and walking. It is possible to utilise factors occurring early in life to inform the likelihood of future motor development in CDD.

Indexed as

Epileptic SyndromesSpasms, InfantileAgedChildChromosome AberrationsFemaleHumansInfant, NewbornMaleProtein Serine-Threonine KinasesCDKL5 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID35978140
PMCPMC9905550
OpenAlexW4292164125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.